Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2014
11/11/2014US8883144 Treatment of pulmonary vascular remodeling with neprilysin
11/11/2014US8883143 Treatment of traumatic-induced migraine headache
11/11/2014US8883142 Fructosyl peptide oxidase
11/11/2014US8883141 Stabilized liquid tenside preparation comprising enzymes
11/11/2014US8883140 Stabilized liquid tenside preparation comprising enzymes
11/11/2014US8883138 Adiponectin production accelerating composition
11/11/2014US8883137 Compositions comprising selenium-rich yeast and yeast beta-glucan
11/11/2014US8883136 Methods for accelerating the healing of connective tissues injuries and disorders
11/11/2014US8883134 Human interleukin-1 receptor antagonist—hybrid Fc fusion protein
11/11/2014US8883120 Polypeptides having affinity for HER2
11/11/2014US8882850 Multi-formed collagenous biomaterial medical device
11/06/2014US20140330252 Biomatrix structural containment and fixation systems and methods of use thereof
11/06/2014US20140330198 Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same
11/06/2014US20140329765 Methods and Compositions for the Treatment of Gastrointestinal Disorders
11/06/2014US20140329764 Novel methods of use of hsp70 for increased performance or treatment of hsp70 related disorders
11/06/2014US20140329761 Prevention and treatment of acute inflammatory conditions
11/06/2014US20140329759 Polyethylene glycol-modified integrin blocker hm-3 and use thereof
11/06/2014US20140329755 Combination therapy for the treatment of arrhythmias or heart failure
11/06/2014US20140329754 Compositions and methods for treating myelodysplastic syndrome
11/06/2014US20140329751 Method for sensitizing cells to cancer therapy
11/06/2014US20140329749 Robust controlled-release peptide formulations
11/06/2014US20140329748 Composition for Controlled Ovarian Stimulation
11/06/2014US20140329747 Compositions and Methods for Treating Renal Failure
11/06/2014US20140329744 Stable non-aqueous liquid pharmaceutical compositions comprising an insulin
11/06/2014US20140329742 Therapeutic peptides
11/06/2014US20140329741 Use of cyclic peptides from flaxseed for improving animal and human health
11/06/2014US20140329740 Anti-infective hydroxy-phenyl-benzoates and methods of use
11/06/2014US20140329738 Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
11/06/2014US20140328943 Insulin compositions and method of making a composition
11/06/2014US20140328940 Modulation of axon degeneration
11/06/2014US20140328933 Novel formulations and methods
11/06/2014US20140328932 Composition comprising n-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity
11/06/2014US20140328928 Stable Aqueous Suspension
11/06/2014US20140328927 Anti-cancer nanoparticle compositions and methods of use
11/06/2014US20140328923 Dosing combinations for reducing undesired humoral immune responses
11/06/2014US20140328922 Local, concomitant administration of tolerogenic synthetic nanocarriers to reduce type i and type iv hypersensitivity
11/06/2014US20140328907 Entrapment of bioactives in sol-gel alumina materials
11/06/2014US20140328901 Methods for using interferon gamma to absorb fluid from the subretinal space
11/06/2014US20140328892 Use of alfimeprase in the treatment of thrombosis
11/06/2014US20140328878 Malleable protein matrix and uses thereof
11/06/2014US20140328866 Peptide-Mediated Non-Covalent Delivery of Active Agents Across the Blood-Brain Barrier
11/06/2014US20140328863 Induction of Differential Stress Resistance and Uses Thereof
11/06/2014US20140328860 Methods for stimulating hematopoietic recovery by inhibiting tgf beta signaling
11/06/2014US20140328857 Novel B7-H3L Cell Surface Antigen and Antibodies That Bind Thereto
11/06/2014US20140328856 Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g
11/06/2014US20140328853 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
11/06/2014US20140328844 Methods of use for taci-immunoglobulin fusion proteins
11/06/2014US20140328826 Product and method for treating keloid scars, hypertrophic scars and burn scars with contracture
11/06/2014US20140328824 Diagnostic and Therapeutic Methods and Their Application in Amyotrophic Lateral Sclerosis (ALS)
11/06/2014US20140328822 Method for preparing highly concentrated fibrinogen solution and method for preparing fibrin sealant by using thereof
11/06/2014US20140328821 Vectors encoding rod-derived cone viability factor
11/06/2014US20140328818 Proteases for Degrading Gluten
11/06/2014US20140328799 Compositions useful for the treatment of viral diseases
11/06/2014US20140328798 Co-Administration of a Parvovirus and a Cytokine for Therapy of Pancreatic Cancer
11/06/2014US20140328796 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
11/06/2014US20140328791 Conjugates of an IL-2 Moiety and a Polymer
11/06/2014US20140328782 Peptide inhibiting matrix metalloproteanases activity and use thereof
11/04/2014US8877902 Formulations and methods for weight loss and body contouring
11/04/2014US8877899 Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL
11/04/2014US8877896 Compositions, methods and kits for modeling, diagnosing, and treating complement disorders
11/04/2014US8877892 Conjugation reactions
11/04/2014US8877891 Method of producing a novel opioid peptide
11/04/2014US8877889 Tumor cell-killing peptides
11/04/2014US8877819 Methods for treating heat stress and related compositions
11/04/2014US8877777 Process for purifying cyclolipopeptide compounds or the salts thereof
11/04/2014US8877738 Antipathogenic peptides
11/04/2014US8877733 1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
11/04/2014US8877727 Delivery of dsRNA to arthropods
11/04/2014US8877726 Method and medicament for inhibiting the expression of a given gene
11/04/2014US8877716 Peptide derivatives, preparation and uses thereof
11/04/2014US8877715 Cytotoxic conjugates having neuropeptide Y receptor binding compound
11/04/2014US8877714 Compositions comprising receptor-associated protein (RAP) variants specific for LRP2 and uses thereof
11/04/2014US8877713 Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
11/04/2014US8877712 Use of Del-1 in hair, bone and cartilage regeneration
11/04/2014US8877711 Octanoate-reduced human albumin
11/04/2014US8877710 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
11/04/2014US8877709 Reversible pegylated drugs
11/04/2014US8877708 Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders
11/04/2014US8877707 Inhibitors of HCV NS5A
11/04/2014US8877706 Maytansinoid derivatives
11/04/2014US8877705 Biomaterial for the controlled delivery of ingredients
11/04/2014US8877494 Human corneal epithelial cell line PTA-120527
11/04/2014US8877478 Phytases, nucleic acids encoding them and methods for making and using them
11/04/2014US8877443 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
11/04/2014US8877261 Anti-redness active agent and cosmetic compositions comprising same
11/04/2014US8877252 Polymer-based sustained release device
11/04/2014US8877251 Powder compositions for inhalation
11/04/2014US8877236 Liposomes active in-vivo on neurodegenerative diseases
11/04/2014US8877228 Treatment of ophthalmic conditions
11/04/2014US8877225 Controlled release copolymer formulation with improved release kinetics
11/04/2014US8877221 Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
11/04/2014US8877207 Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of Alzheimer's disease and associated methods
11/04/2014US8877206 Stimulation of an immune response by cationic lipids
11/04/2014US8877204 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
11/04/2014US8877203 Composition and method for preventing and treating immune-related disorder
11/04/2014US8877196 Methods of altering bone growth by administration of sost or wise antagonist or agonist
11/04/2014US8877193 Transdiscal administration of anti-TNFα antibodies and growth differentiation factors
11/04/2014US8877192 Rage fusion proteins and methods of use
11/04/2014US8877183 Methods for treatment of ocular diseases
11/04/2014US8877180 Human placental collagen compositions, and methods of making and using the same
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 3163